
Nizatidine Oral Solution is a prescription oral product used for the short-term treatment and maintenance therapy of ulcers and for the treatment of esophagitis and associated heartburn due to GERD.
Nizatidine Oral Solution is a prescription oral product used for the short-term treatment and maintenance therapy of ulcers and for the treatment of esophagitis and associated heartburn due to GERD.
Irritable bowel disease, such as ulcerative colitis and Crohn disease, can increase the risk of both cancer and death.
According to a study published in Genome Medicine, the disruption of gut bacteria through the use of antibiotics soon after birth has the ability to affect the immune system’s process of maturation.
A variety of OTC products, such as antacids, histamine H2 receptor antagonists (H2RAs), and proton pump inhibitors (PPIs), are available to help manage symptoms of gastroesophageal reflux disease (GERD).
Next-level digestive enzymes perform vital functions, like breaking down food, eliminating toxins, and even building muscle to amplify healthy habits
According to a recent study published in Gut, inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn disease, is associated with a more than doubled likelihood of developing dementia.
Reducing salt intake to a healthier level appears to be beneficial for the gut microbiome and blood pressure, especially in females with untreated hypertension, according to researchers at the Medical College of Georgia at Augusta University.
The researchers analyzed the National Health Interview Survey 2015 to determine the food intake and frequency of consumption for US adults with IBD.
In a new study, researchers analyzed gut microbiota to understand further the links between gut health and obesity.
Why was a patient prescribed something normally used for stomach problems to help her produce breastmilk?
The clinical practice update incorporates emerging evidence and available guidance for patients with IBD.
The study was the first to examine proton pump inhibitors use in breast cancer survivors.
Tofacitinib, currently used to treat rheumatoid arthritis and ulcerative colitis, has a correcting effect on defects that occur in inflammation.
After some lots of ranitidine were found to contain small amounts of N-nitrosodimethylamine (NDMA), Novartis's Sandoz unit has announced that they are halting distribution of ranitidine (Zantac) products until the contamination concerns are resolved.
Officials from the FDA have announced an approved package size and package type limit for over-the-counter (OTC) brand-name tablet and capsule forms of loperamide.
An over-the-counter and prescription drug, ranitidine is an H2 (histamine-2) blocker that decreases the amount of acid created by the stomach.
Health care professionals can play an important role in managing patients with diarrhea by recommending OTC products for initial treatment.
This edition features 4 case studies with information including adverse effects of fiber consumption, using ginger for morning sickness, help for dysmenorrhea, and products for heartburn.
Pharmacists are instrumental in guiding patients on the appropriate and safe use of products for gastrointestinal discomfort.
Just 22% of those who suffer seek help from a health care provider, newer agents show promise.
Diet and lifestyle changes are key components of treating gastroesophageal reflux disease.
Pharmacists can, and should, play an important role in counseling patients before they travel anywhere about what to do in the event of a GI illness while vacationing.
Travel health services involves a lot more than vaccinations, said Sheri Stensland, PharmD, in a session at McKesson ideaShare.
Parvus Therapeutics and Genentech have entered into a worldwide collaboration and licensing agreement for the development, manufacturing, and commercialization of treatments for inflammatory bowel disease, autoimmune liver diseases, and celiac disease using nanomedicines (Navacim) developed by Parvus.
Rifamycin's effectiveness was shown in a randomized, placebo-controlled clinical trial during which the drug significantly reduced symptoms of travelers’ diarrhea in adults afflicted with the condition in Guatemala and Mexico.